Ao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ao Li has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Guoqiang Wan
Ministry of Education Key Laboratory of Model Animal for Disease Study, Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), the Affiliated Drum Tower Hospital of Medical School and the Model Animal Research Center of Medical School, Nanjing University, Nanjing 210008, China
3 shared publications Qing Liu
2 shared publications- Xiaoyun Qian
Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
2 shared publications Chenxuan Yong
1 shared publication- Da-Jian Jv
School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing, China
1 shared publication Dengbin Ma
Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
1 shared publication
Latest Publications
- 13 October 2026
- Published by Elsevier in Journal of Genetics and Genomics
DNAJC17 regulates RNA splicing in auditory hair cells and is required for hearing
- 13 October 2026
- Published by Elsevier in Journal of Genetics and Genomics
DNAJC17 regulates RNA splicing in auditory hair cells and is required for hearing
- Open Access
Hypoxia-Stabilized HIF1α Restricts Hair Cell Reprogramming by Suppressing Wnt Signaling in the Mammalian Cochlea
Sensorineural hearing loss, caused by irreversible hair cell (HC) loss, remains incurable due to the inability of the mammalian cochlea to regenerate HCs spontaneously. Although the combinatorial modulation of Notch and Wnt signaling robustly reprograms cochlear supporting cells to HCs in vitro, these strategies show limited success in vivo, which suggests that the native cochlear microenvironment imposes inhibitory cues. Here, we identify hypoxia-inducible factor 1α (HIF1α) as a critical barrier to HC reprogramming in vivo. We found that HIF1α accumulates in the basilar membrane of the intact cochlea, whereas ex vivo culture rapidly eliminates this accumulation. Mimicking the in vivo hypoxic state recapitulated the reprogramming blockade, hindering supporting cells from completing the fate transition to HCs. Mechanistically, HIF1α selectively suppressed Wnt signaling, as evidenced by the reduced expression of Wnt target genes and Wnt10a. Importantly, the pharmacological inhibition of HIF1α rescued the impaired reprogramming under hypoxia. These findings demonstrate that HIF1α accumulation in the hypoxic cochlear environment antagonizes Wnt-mediated HC differentiation, providing a mechanistic explanation for the failure of in vivo regeneration. Targeting HIF1α to restore supporting cell reprogramming competence within the hypoxic cochlear niche represents a promising, clinically translatable strategy for functional HC regeneration and hearing restoration.
Open AccessHypoxia-Stabilized HIF1α Restricts Hair Cell Reprogramming by Suppressing Wnt Signaling in the Mammalian Cochlea
Sensorineural hearing loss, caused by irreversible hair cell (HC) loss, remains incurable due to the inability of the mammalian cochlea to regenerate HCs spontaneously. Although the combinatorial modulation of Notch and Wnt signaling robustly reprograms cochlear supporting cells to HCs in vitro, these strategies show limited success in vivo, which suggests that the native cochlear microenvironment imposes inhibitory cues. Here, we identify hypoxia-inducible factor 1α (HIF1α) as a critical barrier to HC reprogramming in vivo. We found that HIF1α accumulates in the basilar membrane of the intact cochlea, whereas ex vivo culture rapidly eliminates this accumulation. Mimicking the in vivo hypoxic state recapitulated the reprogramming blockade, hindering supporting cells from completing the fate transition to HCs. Mechanistically, HIF1α selectively suppressed Wnt signaling, as evidenced by the reduced expression of Wnt target genes and Wnt10a. Importantly, the pharmacological inhibition of HIF1α rescued the impaired reprogramming under hypoxia. These findings demonstrate that HIF1α accumulation in the hypoxic cochlear environment antagonizes Wnt-mediated HC differentiation, providing a mechanistic explanation for the failure of in vivo regeneration. Targeting HIF1α to restore supporting cell reprogramming competence within the hypoxic cochlear niche represents a promising, clinically translatable strategy for functional HC regeneration and hearing restoration.
- Open Access
- 12 August 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (33)
Blood–labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus
Hearing loss (HL) in patients with systemic lupus erythematosus (SLE) has been widely reported, though the underlying mechanisms remain unclear. In this study, we demonstrate significant HL in an imiquimod-induced mouse model of SLE, accompanied by blood–labyrinth barrier (BLB) damage in the stria vascularis (SV). We found that cytotoxic CD8 + T lymphocytes and natural killer cells mediate BLB disruption, with granzyme b (Gzmb) acting as the primary factor inducing cell death of the cochlear capillary endothelial cells. Remarkably, inhibiting Gzmb by Serpinb9 significantly alleviates the elevations of hearing thresholds in imiquimod-induced SLE model mice, suggesting a therapeutic target for autoimmune-related HL. Our findings provide insights into the pathogenesis of SLE-related HL and propose Gzmb inhibition as a potential therapeutic strategy.
- 12 August 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (33)
Open AccessBlood–labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus
Hearing loss (HL) in patients with systemic lupus erythematosus (SLE) has been widely reported, though the underlying mechanisms remain unclear. In this study, we demonstrate significant HL in an imiquimod-induced mouse model of SLE, accompanied by blood–labyrinth barrier (BLB) damage in the stria vascularis (SV). We found that cytotoxic CD8 + T lymphocytes and natural killer cells mediate BLB disruption, with granzyme b (Gzmb) acting as the primary factor inducing cell death of the cochlear capillary endothelial cells. Remarkably, inhibiting Gzmb by Serpinb9 significantly alleviates the elevations of hearing thresholds in imiquimod-induced SLE model mice, suggesting a therapeutic target for autoimmune-related HL. Our findings provide insights into the pathogenesis of SLE-related HL and propose Gzmb inhibition as a potential therapeutic strategy.
- Open Access
- 5 June 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Novel Surgery Approaches in Laryngopharyngeal Schwannomas: A Retrospective Analysis
Purpose: Laryngeal schwannoma is a rare condition with limited research. This case series presents cases of laryngeal schwannoma in our department with details on the surgical approaches and prognosis of patients, in order to add more evidence for this setting. Methods: The patients presented with symptoms that suggested diseases in the throat. These patients were examined by laryngoscopy, magnetic resonance imaging (MRI), and computed tomography (CT). Depending on the tumor size and location, trans-oral endoscopic (laser-assisted) resection, or open laryngeal surgery was applied. The open surgery was modified by splitting the thyroid cartilage plate in the middle (not entering the larynx) and separating the inner surface of the thyroid cartilage plate on the affected side. Results: The tumors of all patients were successfully removed. Then, these patients were followed up at the 1st, 3rd, and 6th month after surgery through clinic visits. Laryngoscopy, MRI, and CT were performed to examine the patients, and no recurrences were detected. Conclusion: The changes applied for the procedure presented in the present study have the potential to reduce recovery time and scarring, and help preserve throat function. The investigators consider these as potential alternatives to existing methods for treating laryngeal schwannomas. However, more research is required to refine the methods used to treat schwannomas and to ensure that patients receive the best care.
- 5 June 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessNovel Surgery Approaches in Laryngopharyngeal Schwannomas: A Retrospective Analysis
Purpose: Laryngeal schwannoma is a rare condition with limited research. This case series presents cases of laryngeal schwannoma in our department with details on the surgical approaches and prognosis of patients, in order to add more evidence for this setting. Methods: The patients presented with symptoms that suggested diseases in the throat. These patients were examined by laryngoscopy, magnetic resonance imaging (MRI), and computed tomography (CT). Depending on the tumor size and location, trans-oral endoscopic (laser-assisted) resection, or open laryngeal surgery was applied. The open surgery was modified by splitting the thyroid cartilage plate in the middle (not entering the larynx) and separating the inner surface of the thyroid cartilage plate on the affected side. Results: The tumors of all patients were successfully removed. Then, these patients were followed up at the 1st, 3rd, and 6th month after surgery through clinic visits. Laryngoscopy, MRI, and CT were performed to examine the patients, and no recurrences were detected. Conclusion: The changes applied for the procedure presented in the present study have the potential to reduce recovery time and scarring, and help preserve throat function. The investigators consider these as potential alternatives to existing methods for treating laryngeal schwannomas. However, more research is required to refine the methods used to treat schwannomas and to ensure that patients receive the best care.
- 8 October 2022
- Published by Elsevier in Food Chemistry
- Vol. 405 (Pt A) , 134551
The remarkable enhancement of photo-stability and antioxidant protection of lutein coupled with carbon-dot
- 8 October 2022
- Published by Elsevier in Food Chemistry
- Vol. 405 (Pt A) , 134551
The remarkable enhancement of photo-stability and antioxidant protection of lutein coupled with carbon-dot
- 1 July 2018
- Published by Elsevier in European Journal of Pharmacology
- Vol. 830, 17-25
Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells
- 1 July 2018
- Published by Elsevier in European Journal of Pharmacology
- Vol. 830, 17-25
Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells